MetaCap

Utah Medical Products Inc. (UTMD)

NASDAQ: UTMDHealth CareMedical/Dental InstrumentsUSD

69.49-1.47 (-2.07%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

UTMD stock chart

Technical analysis

Key statistics

All statistics
Market cap
$198.01M
Dividend yield
1.78% ($1.24)
Ex-dividend date
Dec 17, 2026
52-week range
53.80 – 76.89
Day range
69.49 – 71.67
Volume / Avg
29.99K / 33.70K
Beta
—
Next earnings
Jan 28, 2027

52-week range

$53.80$76.89

UTMD stock today

On Nov 20, UTMD ended the session at $69.49, shedding $1.47 (2.07%), versus the S&P 500's 3.70% decline. At this level, UTMD sits in the middle of its 52-week range of $53.80 to $76.89: 9.6% below the high, set on Sep 22, 2026 and 29.2% above the low. UTMD is up 24.2% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 26.0%.

Utah Medical Products trades at 20.8x its trailing twelve-month earnings per share of $3.34. Utah Medical Products's next earnings report is expected on Jan 28, 2027. Utah Medical Products pays an annual dividend of $1.24 per share, a 1.78% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Utah Medical Products

Company profile

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.

Industry
Medical/Dental Instruments
CEO
Mr. Kevin L. Cornwell
Headquarters
Midvale, UT
Employees
140

Financial highlights

Full financials

In fiscal 2025, Utah Medical Products generated $38.5 million in revenue, down 5.8% from fiscal 2024, its first annual decline since 2024. Net income was $11.3 million (-18.7% year over year), for a net margin of 29.3% versus a median of 31.5% in the prior 5 years. Gross margin was 57.1% (down from 59.0%) and operating margin 29.6%.

Utah Medical Products annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$38.52M$40.90M$50.22M$52.28M$49.05M
Growth-5.83%-18.56%-3.93%+6.58%+16.30%
Net income$11.29M$13.87M$16.64M$16.47M$14.79M
EPS (diluted)$3.48$3.96$4.57$4.52$4.04

Earnings

Earnings history
Next report
Jan 28, 2027
Last reported (Sep/2026)
Oct 22, 2026
EPS actual vs est.
$0.88 vs —

Dividends

Dividend history
Annual dividend
$1.24
Last payment
$0.315
Ex-dividend date
Dec 17, 2026
Pay date
Jan 5, 2027

UTMD news

All UTMD news

Utah Medical Products peers

Health Care sector
UTMD peer companies
CompanyPrice% ChgMarket capCompare
PDEXPro-Dex Inc.63.00-0.77%$201.60Mvs UTMD
KTWOK2 Capital Acquisition Corporation Class A10.130.00%$203.02Mvs UTMD
ANIKAnika Therapeutics Inc.13.23-0.38%$177.22Mvs UTMD
CLPTClearPoint Neuro Inc.6.91-5.47%$221.49Mvs UTMD
PROFProfound Medical Corp.6.38-3.19%$233.68Mvs UTMD
OSUROraSure Technologies Inc.3.46-4.16%$238.90Mvs UTMD
OFIXOrthofix Medical Inc.6.07-4.26%$247.41Mvs UTMD
SSIISS Innovations International Inc.1.27-0.78%$254.86Mvs UTMD

Indexes, lists and sector

Utah Medical Products stock FAQ

What is Utah Medical Products's stock price today?

UTMD last traded at $69.49 as of Nov 20, 4:00 PM EST, down 2.07% on the day. Prices are delayed at least 15 minutes.

Does Utah Medical Products pay a dividend?

Yes. Utah Medical Products pays $1.24 per share annually, a 1.78% yield. The most recent dividend of $0.315 had an ex-dividend date of Dec 17, 2026.

When is Utah Medical Products's next earnings date?

Utah Medical Products is expected to report earnings on Thursday, January 28, 2027.

What is UTMD's P/E ratio?

UTMD trades at a trailing P/E ratio of 20.81.

Who is Utah Medical Products's CEO?

Mr. Kevin L. Cornwell is the chief executive officer of Utah Medical Products Inc., which has about 140 employees.

What is the UTMD 52-week high?

The 52-week high for UTMD is $76.89 and the 52-week low is $53.80. The stock is currently 9.6% below its high.

Compare UTMD